Policy | February 24, 2026
India shifts focus from 'Pharmacy of the World' to 'Global Innovation Hub', says Health Minister Nadda
Nadda underlined that India’s policy framework is aligned with this transformation
Nadda underlined that India’s policy framework is aligned with this transformation
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
Samsung Health users can now order medicines, book lab tests and online consultations through PharmEasy, along with 6 months of complimentary PharmEasy Plus membership
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Subscribe To Our Newsletter & Stay Updated
